VF Mapping in Brugada and Early Repolarization Syndromes (NCT03764592) | Clinical Trial Compass
CompletedNot Applicable
VF Mapping in Brugada and Early Repolarization Syndromes
Thailand50 participantsStarted 2018-02-23
Plain-language summary
To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with BrS and Early Repolarization.
Who can participate
Age range16 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients presenting with the type1 BrS ECG or ER ECG signature pattern, with/without a sodium channel blocker. Patients with the following one of these symptoms or arrhythmias will be considered as symptomatic patients: 1) aborted cardiac arrest cases, 2) documented VF episodes, 3) agonal respiration during sleep with difficulty to arouse, 4) syncope of unknown origin, or 5) seizure suspected of arrhythmic origin.•
Exclusion Criteria:
Patients who refuse informed consent and to participate to the best ability in the study.
Patients who have structural heart disease or concomitant medical illness.
What they're measuring
1
VF death
Timeframe: 3 years
Trial details
NCT IDNCT03764592
SponsorPacific Rim Electrophysiology Research Institute